Physician profile
Daniel E Vera
NPI 1851476212
$12,569.72
in general payments reported to CMS, 2019-2025
24 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,102 · 2020: $1,008 · 2021: $614 · 2022: $2,293 · 2023: $215 · 2024: $720 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,553.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,552.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,622.56 | 2019-2024 | |
| Allergan, INC. | $1,710.78 | 2019 | |
| Baxter Healthcare | $890.00 | 2020 | |
| Stryker Corporation | $621.06 | 2021-2023 | Spy-Phi System |
| Davol INC. | $495.93 | 2025 | Phasix Mesh |
| Boston Scientific Corporation | $358.95 | 2022-2025 | Spyglass Discover, Overstitch Endoscopic Suturing System |
| Tela Bio, INC. | $311.95 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Lemaitre Vascular, INC. | $236.80 | 2023-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft, Trivex System |
| Kerecis Limited | $234.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| W. L. Gore & Associates, INC. | $198.12 | 2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Olympus America INC. | $148.05 | 2024 | Endocapsule Recorder, Visiglide, Hanarostent Esophagus Tts(Ccc) |
| Aroa Biosurgery Incorporated | $144.13 | 2024 | |
| Organogenesis INC. | $121.41 | 2025 | Puraply Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $116.95 | 2022-2025 | Gattex, Entyvio |
| Medtronic, INC. | $85.23 | 2025 | Pteye Parathyroid Detection System |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioptics, INC. | $75.66 | 2019 | |
| Smith+Nephew, INC. | $58.33 | 2019 | |
| Kci USA, INC. | $28.45 | 2019-2021 | |
| Amgen INC. | $22.60 | 2019 | |
| Activ Surgical, INC. | $20.71 | 2022 | |
| Mimedx Group, INC. | $18.63 | 2025 | |
| Tactile Systems Technology INC | $18.41 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $17.16 | 2024 | Exparel |
| Thd America, INC. | $12.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Vera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.